Skip to main content

Advertisement

Log in

Unklare Hüftschmerzen bei systemischer Sklerodermie

Osteonekrose

Unclear hip pain in systemic sclerosis

Osteonecrosis

  • Kasuistiken
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

Zusammenfassung

Die systemische Sklerodermie (SSc) ist eine immunologisch vermittelte entzündliche Bindegewebskrankheit der Haut und zahlreicher extrakutaner Organe, die zu einer ausgedehnten Vaskulopathie kleiner Gefäße und progressiver Fibrose führt. Eine oft wenig beachtete Organmanifestation stellt das Knochengewebe dar. Wir berichten über eine Patientin mit diffuser SSc, bei der es 4 Jahre nach Diagnosestellung der Sklerodermie zu therapieresistenten Schmerzen im Hüftbereich rechts kam. Schmerzursache war eine nichttraumatische Osteonekrose des Caput femoris, die erst mittels MRT diagnostiziert werden konnte.

Abstract

Systemic sclerosis (SSc) is an immune-mediated inflammatory disease of connective tissue that leads to widespread small vessel damage, progressive fibrosis of the skin and numerous extracutaneous organs. An often forgotten manifestation of SSc is in bone. We report on a case of SSc where the patient suffered from unexplainable coxalgia that had started 4 years after the diagnosis of SSc was made. Nontraumatic osteonecrosis of the femoral head was identified by magnetic resonance imaging (MRI) as the underlying cause of the hip pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Cavallasca JA et al (2005) Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome. Clin Rheumatol 24:406–408

    Article  PubMed  Google Scholar 

  2. Drescher W et al (2011) Hüftkopfnekrose – Diagnostik und Differenzialtherapie. Z Orthop Unfall 149:231–242

    Article  PubMed  CAS  Google Scholar 

  3. Fossaluzza V, Peressini A, De Vita S (1991) Multifocal ischemic necrosis of bone in scleroderma. Clin Rheumatol 10:95–97

    Article  PubMed  CAS  Google Scholar 

  4. Hofmann S, Kramer J, Plenk H Jr (2005) Die Osteonekrose des Hüftgelenks im Erwachsenenalter. Orthopäde 34:171–183

    Article  PubMed  CAS  Google Scholar 

  5. Kahaleh B (2008) Vascular disease in scleroderma: mechanisms of vascular injury. Rheum Dis Clin North Am 34:57–71

    Article  PubMed  Google Scholar 

  6. Katsumoto TR, Whitfield ML, Connolly MK (2011) The pathogenesis of systemic sclerosis. Annu Rev Pathol 6:509–537

    Article  PubMed  CAS  Google Scholar 

  7. Kerachian MA, Séguin C, Harvey EJ (2009) Glucocorticoids in osteonecrosis of the femoral head: a new understanding of mechanisms of action. J Steroid Biochem Mol Biol 114:121–128

    Article  PubMed  CAS  Google Scholar 

  8. Klippel JH et al (1979) Avascular necrosis in systemic lupus erythematosus. Silent symmetric osteonecrosis. Am J Med 67:83–87

    Article  PubMed  CAS  Google Scholar 

  9. Koch AE, Distler O (2007) Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 9(Suppl 2):1–9

    Article  Google Scholar 

  10. Kunyakham W et al (2012) Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. Asian Pac J Allergy Immunol 30:152–157

    PubMed  Google Scholar 

  11. Martinez-Cordero E (1992) Avascular necrosis of bone in systemic sclerosis. Clin Rheumatol 11:443–444

    Article  PubMed  CAS  Google Scholar 

  12. Picillo U et al (1995) Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis. Autoimmunity 20:1–7

    Article  PubMed  CAS  Google Scholar 

  13. Powell C et al (2010) Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev 9:721–743

    Article  PubMed  CAS  Google Scholar 

  14. Sayarlioglu M et al (2012) Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int 32:177–182

    Article  PubMed  CAS  Google Scholar 

  15. Shah AA, Wigley FM (2008) Often forgotten manifestations of systemic sclerosis. Rheum Dis Clin North Am 34:221–238

    Article  PubMed  Google Scholar 

  16. Shigemura T et al (2011) Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospektive MRI study. Rheumatology 50:2023–2028

    Article  PubMed  CAS  Google Scholar 

  17. Steen V, Medsger TA (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619

    Article  PubMed  CAS  Google Scholar 

  18. Taccari E et al (1989) Avascular necrosis of the femoral head in long-term follow-up of systemic sclerosis. report of two cases. Clin Rheumatol 8:386–392

    Article  PubMed  CAS  Google Scholar 

  19. Trang G et al (2012) Corticosteroids and the risk of scleroderma renal crisis: a systematic review. Rheumatol Int 32:645–653

    Article  PubMed  CAS  Google Scholar 

  20. Wilde AH, Mankin HJ, Rosnan GP (1970) Avascular necrosis of the femoral head in scleroderma. Arthritis Rheum 13:445–447

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Buslau MSc.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buslau, M., Spitzenberger, D. Unklare Hüftschmerzen bei systemischer Sklerodermie. Z. Rheumatol. 72, 601–605 (2013). https://doi.org/10.1007/s00393-013-1152-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-013-1152-7

Schlüsselwörter

Keywords

Navigation